TABLE 4.

The time of onset and resolution of adverse events related to immune checkpoint inhibitors are depicted below.

	Median time of onset in months (95% CI)	Median time to resolution in months (95% CI)
Hepatitis	1.47 (0–4.0)	0.6 (0–2)
Pneumonitis	2.53 (0.9–4.2)	24 days (resolved in 2 patients out of 7)
Colitis	3.9 (0–8)	0.8 (0–2.3)
Nephritis	0.5 (0–1.6)	8.8 (1–16.5)
Adrenal insufficiency	3.1 (0–7.5)	Resolved in 1 patient after 120 days
Fatigue	1.4 (0.1–2.6)	5.8 (1.9–10)
Anorexia	1.3 (1.0–1.6)	2.3 (1.4–3.2)

Abbreviations: CI, confidence interval.